SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options on January 25, 2018 to four (4 …

SAN DIEGO, July 25, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options on July 19, 2017 to four (4) …

SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options on May 4, 2017 to eight (8) new …

… , including rates of MSC patents, grants, scientific publications, and clinical trials … Cynata Therapeucics Ltd. 11.28 Cytori Therapeutics Inc. 11.29 Escape Therapeutics …

… 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐫𝐞𝐚𝐬𝐨𝐧 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐓𝐡𝐞 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: BrainStorm Cell Limited, Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Fibrocell … a$500,000 grant previously awarded to …

… ’s arbitrary-and-capricious standard. Cytori Therapeutics, Inc. v. FDA, 715 F … ) (Roberts, C.J., concurring in grant of application for stay). PhRMA …

… Expands Regenerative Therapies Business Entity Cytori Therapeutics, Inc Expands Class III … Business Innovation Research (SBIR) Grant from National Institutes of Health … States) Cryolife Inc. (United States) Cytori Therapeutics, Inc. (United States) Depuy …

… changed its name from "Cytori Therapeutics, Inc." to "Plus … the shares available for future grant under the Company's …

… officially changed its name from “Cytori Therapeutics, Inc.” to “Plus Therapeutics, Inc … the shares available for future grant under the Company’s Amended …